The move could open the way for the very youngest in the country to start receiving shots as early as March.
Pfizer on Tuesday asked the U.S. to authorize extra-low doses of its COVID-19 vaccine for children under 5, potentially opening the way for the country’s very youngest to start receiving shots as early as March.had urged Pfizer and its partner BioNTechThe nation’s 19 million children under 5 are the only group not yet eligible for vaccination against the coronavirus.
The agency’s decision could come within weeks, but that isn’t the only hurdle. The Centers for Disease Control and Prevention also has to sign off. While young children are far less likely than adults to get severely ill from the coronavirus, it can happen, and pediatric COVID-19 infections are higher than at any other point in the pandemic.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer submits request for COVID-19 vaccine use in children under age 5Pfizer and BioNTech said Tuesday that the companies had asked the Food and Drug Administration (FDA) to authorize their COVID-19 vaccine for emergency use in children younger than 5 years old.
Weiterlesen »
Pfizer asks FDA to allow COVID-19 vaccine for kids under 5Pfizer on Tuesday asked the U.S. to authorize extra-low doses of its COVID-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to start receiving shots as early as March.
Weiterlesen »
Pfizer asks FDA to allow COVID-19 vaccine for kids under 5Children under the age of 5 are the only group not yet eligible for vaccination — but that could change soon.
Weiterlesen »
Pfizer Asks FDA to Allow COVID-19 Vaccine for Kids Under 5The nation’s 19 million children under 5 are the only group not yet eligible for vaccination against the coronavirus.
Weiterlesen »
Regulators urge Pfizer to apply for COVID-19 vaccines for kids under 5Early Pfizer data has shown the vaccine — which is administered to younger kids at one-tenth the strength of the adult shot — is safe and produces an immune response.
Weiterlesen »